Status:
RECRUITING
Evaluation of On-Couch CBCT Image Quality
Lead Sponsor:
Varian, a Siemens Healthineers Company
Conditions:
Head and Neck Cancer
Thoracic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, single-arm, single-site study designed to generate data describing the image quality and applicability/useability of a high-performance, on-couch CBCT imaging technology (HyperS...
Eligibility Criteria
Inclusion
- Patient age is ≥ 18 years old.
- Patient has a diagnosis of primary or metastatic cancer, including but not limited to tumors arising from or involving the head/neck, lungs, liver, pancreas, prostate, urinary bladder, rectum, cervix or uterus.
- A previous (standard-of-care) decision was made to treat the patient with radiation therapy using a Varian TrueBeam treatment system.
- A previous (standard-of-care) decision was made to treat the patient with a radiation dose of at least 20 Gy in at least 5 fractions, one fraction per day on consecutive days, Monday to Friday.
- Patient is willing and able to provide informed consent to participate in the study.
Exclusion
- Patient is pregnant or has plans for pregnancy during the period of treatment.
- Patient is part of a vulnerable population (per ISO 14155:2020, "individuals who are unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response").
Key Trial Info
Start Date :
October 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06576908
Start Date
October 17 2024
End Date
December 1 2025
Last Update
December 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre (University Health Network)
Toronto, Ontario, Canada, M5G 2M9